Emerging Enterprises Committee Webinar
Commercialization: Building the Custom Fit for Success
Monday, March 19, 2018
12:00 - 1:00 p.m. (Eastern)
11:00 a.m. - 12:00 p.m. (Central)
10:00 - 11:00 a.m. (Mountain)
9:00 - 10:00 a.m. (Pacific)
Case study/experience based reflection on IA management focused on start-up and its growth phases: how to work through the assessment of a technology to determine the most appropriate pathway and share innovative models for achieving commercialization with development of NantKwest (life science) as a start-up example.
Gary Keller - CEO, Xomix Ltd.
Gary Keller is CEO of Xomix Ltd., a global technology accelerator and consultancy providing intellectual asset management, commercialization, and global businesses development services. Keller has more than 30 years of experience in international business development for leading biotechnology companies and is responsible for the development, funding and launch of numerous technology and commercialization initiatives and startup companies. He has addressed a broad range of intellectual property, technology transfer and tech startup topics in presentations around the world as a keynote speaker, moderator or panelist on behalf of the USPTO and other organizations.
He is President and Managing Director of the Midwest University Research Network (MRUN) and Cofounder and Industry Chairman of H20TECH, a Water Innovation Cluster for the Southeast U.S. He is author of the World Intellectual Property Organization (WIPO) Guide to Commercialization of Intellectual Property and workshops. His startups include NantKwest (NK NASDAQ), a San Diego based Immuno-oncology Company and the Florida Institute for Commercialization of Public Research. Keller is a cofounder and Industry Chairman of H2OTECH, an Atlanta based EPA Water Innovation Cluster for the Southeast seven United States and an Advisor for Cleantech Open Midwest.
He is and International Delegate and cofounder and Chairman Emeritus of the LES USA Canada Emerging Enterprise Committee, and LESI Vice President for Life Sciences and a LESI Advisor for WIPO GRE and WIPO Research. He is the author of the WIPO Guide on the Commercialization of Intellectual Property and the affiliated workshop. He is a member of AUTM, served as Co-Chair BIO Technology Transfer Committee and served for on the Board of Trustees of Sinai Hospital System - Chicago. Keller has a Masters of Biotechnology from Northwestern University, a Bachelor’s of Science from Pennsylvania State University, and is graduate of Second City Improv, Chicago.